Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107661 · ClinicalTrials.gov registry record
Colorectal Screening Strategies in Underserved Populations
A clinical trial, sponsored by Virtua Health.
- Terminated
- Registry status
- 62
- Enrollment target
NCT05107661: Clinical Trial study, sponsored by Virtua Health.
NCT05107661 is a clinical trial that was terminated before completion, run by Virtua Health. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107661 was terminated before completion, sponsored by Virtua Health.
- TERMINATED
- Registry status
- 62 participants
- Enrollment target
Study Summary
Research efforts are necessary to identify strategies to increase colorectal screening in underserved patient populations. Racial, ethnic minorities and medically underserved individuals continue to experience disparities in colorectal cancer mortality despite the availability of screening tests that can detect tumors early when treatments are most effective.
Primary Outcome
To determine the effectiveness of digital reminders versus telephone reminders to prompt participants to follow through with completing their colonoscopy. Comparison of the success or failure of digital versus phone call reminders will be measured. To determine the effectiveness of digital reminders versus phone reminders to follow through with completing fecal testing to screen for colorectal cancer. Comparison of the success or failure of digital versus phone call reminders will be measured.
Interventions
- BEHAVIORAL Telephone Prompt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2021-09-26 |
| Est. Completion | 2023-08-09 |
Why NCT05107661 stopped before completion
NCT05107661 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Telephone Prompt is the first listed.
NCT05107661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05107661 about?
NCT05107661 is a clinical study titled "Colorectal Screening Strategies in Underserved Populations". Research efforts are necessary to identify strategies to increase colorectal screening in underserved patient populations. Racial, ethnic minorities and medically underserved individuals continue to experience disparities in colorectal cancer mortality despite the availability of screening tests tha...
What is the current status of trial NCT05107661?
This trial is currently terminated. The enrollment target is 62 participants. The study started on 2021-09-26. Estimated completion is 2023-08-09.
What interventions are being tested in trial NCT05107661?
The interventions under investigation include: Telephone Prompt (BEHAVIORAL).
Who is sponsoring clinical trial NCT05107661?
This trial is sponsored by Virtua Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI